Search research articles
Contact Us
Filters
Showing results (1-10 of 73) with videos related to
Page
of 8
Sort By:
Journal of Immunological Methods
|
September 6, 2003
Study of T-cell signaling by somatic cell mutagenesis and complementation cloning
Mary Ellen Cvijic, Gutian Xiao, Shao-Cong Sun
Drug Discovery Today. Technologies
|
January 3, 2016
GPCR profiling: from hits to leads and from genotype to phenotype
Mary Ellen Cvijic, Chi Shing Sum, Andrew Alt, et al.
Journal of Biomolecular Screening
|
April 21, 2016
384-Well Multiplexed Luminex Cytokine Assays for Lead Optimization
Huaping Tang, Reshma Panemangalore, Melissa Yarde, et al.
Assay and Drug Development Technologies
|
May 13, 2011
Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells
Yuren Wang, Yan Kong, Gan Ju Shei, et al.
Journal of Laboratory Automation
|
April 17, 2012
GPCR assay automation for leveraging lead optimization
Mary Ellen Cvijic, Jing Chen, Steve Kubala, et al.
The Biochemical Journal
|
April 20, 2021
Integrin αVβ1 regulates procollagen I production through a non-canonical transforming growth factor β signaling pathway in human hepatic stellate cells
Zuoning Han, Yanling Ma, Gary Cao, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 4, 2024
Perspectives on phenotypic screening-Screen Design and Assay Technology Special Interest Group
Chorom Pak, Kaylene J Simpson, Andrea D Weston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 12, 2013
Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump
A David Rodrigues, Yurong Lai, Mary Ellen Cvijic, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 4, 2020
Enabling direct and definitive free fraction determination for highly-bound compounds in protein binding assay
Jun Zhang, Gabriela Pikul, John Horch, et al.
Drug Discovery Today
|
March 20, 2012
Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004-2009
Litao Zhang, Mary Ellen Cvijic, Jonathan Lippy, et al.
Page
of 8
Search research articles
Search
Showing results (1-10 of 73) with videos related to
Sort By:
Page
of 8
Journal of Immunological Methods
|
September 6, 2003
Study of T-cell signaling by somatic cell mutagenesis and complementation cloning
Mary Ellen Cvijic, Gutian Xiao, Shao-Cong Sun
Drug Discovery Today. Technologies
|
January 3, 2016
GPCR profiling: from hits to leads and from genotype to phenotype
Mary Ellen Cvijic, Chi Shing Sum, Andrew Alt, et al.
Journal of Biomolecular Screening
|
April 21, 2016
384-Well Multiplexed Luminex Cytokine Assays for Lead Optimization
Huaping Tang, Reshma Panemangalore, Melissa Yarde, et al.
Assay and Drug Development Technologies
|
May 13, 2011
Development of a cyclic adenosine monophosphate assay for Gi-coupled G protein-coupled receptors by utilizing the endogenous calcitonin activity in Chinese hamster ovary cells
Yuren Wang, Yan Kong, Gan Ju Shei, et al.
Journal of Laboratory Automation
|
April 17, 2012
GPCR assay automation for leveraging lead optimization
Mary Ellen Cvijic, Jing Chen, Steve Kubala, et al.
The Biochemical Journal
|
April 20, 2021
Integrin αVβ1 regulates procollagen I production through a non-canonical transforming growth factor β signaling pathway in human hepatic stellate cells
Zuoning Han, Yanling Ma, Gary Cao, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
February 4, 2024
Perspectives on phenotypic screening-Screen Design and Assay Technology Special Interest Group
Chorom Pak, Kaylene J Simpson, Andrea D Weston, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|
October 12, 2013
Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump
A David Rodrigues, Yurong Lai, Mary Ellen Cvijic, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
December 4, 2020
Enabling direct and definitive free fraction determination for highly-bound compounds in protein binding assay
Jun Zhang, Gabriela Pikul, John Horch, et al.
Drug Discovery Today
|
March 20, 2012
Case study: technology initiative led to advanced lead optimization screening processes at Bristol-Myers Squibb, 2004-2009
Litao Zhang, Mary Ellen Cvijic, Jonathan Lippy, et al.
Page
of 8